- Report
- April 2024
- 402 Pages
Global
From €4779EUR$4,950USD£4,047GBP
- Report
- January 2024
- 293 Pages
Global
From €4779EUR$4,950USD£4,047GBP
- Report
- December 2023
- 307 Pages
Global
From €4779EUR$4,950USD£4,047GBP
- Report
- August 2023
- 370 Pages
Global
From €2404EUR$2,490USD£2,036GBP
- Report
- July 2023
- 210 Pages
Global
From €1921EUR$1,990USD£1,627GBP
- Report
- October 2023
- 192 Pages
Global
From €4828EUR$5,176USD£3,950GBP
- Report
- May 2024
- 391 Pages
Global
From €5317EUR$5,700USD£4,350GBP
- Report
- March 2024
- 239 Pages
Global
From €5317EUR$5,700USD£4,350GBP
- Report
- February 2024
- 270 Pages
Global
From €5317EUR$5,700USD£4,350GBP
- Report
- December 2023
- 261 Pages
Global
From €4828EUR$5,176USD£3,950GBP
- Report
- November 2023
- 312 Pages
Global
From €5317EUR$5,700USD£4,350GBP
- Report
- November 2023
- 215 Pages
Global
From €4828EUR$5,176USD£3,950GBP
- Report
- September 2023
- 303 Pages
Global
From €4828EUR$5,176USD£3,950GBP
- Report
- August 2023
- 235 Pages
Global
From €4828EUR$5,176USD£3,950GBP
- Report
- June 2023
- 364 Pages
Global
From €4828EUR$5,176USD£3,950GBP
- Report
- June 2023
- 308 Pages
Global
From €4828EUR$5,176USD£3,950GBP
- Report
- May 2024
- 248 Pages
Global
From €4779EUR$4,950USD£4,047GBP
- Report
- April 2024
- 195 Pages
Global
From €1921EUR$1,990USD£1,627GBP
- Report
- March 2024
- 192 Pages
Global
From €3258EUR$3,374USD£2,759GBP
€3620EUR$3,749USD£3,065GBP
- Report
- March 2024
- 195 Pages
Global
From €3258EUR$3,374USD£2,759GBP
€3620EUR$3,749USD£3,065GBP
![Loading Indicator](//www.researchandmarkets.com/images/loading.gif)
The biopharmaceuticals market is a sector of the pharmaceutical industry that focuses on the development and production of drugs derived from biological sources. These drugs are typically produced using recombinant DNA technology, which involves the manipulation of genetic material to create proteins and other molecules with therapeutic properties. Biopharmaceuticals are used to treat a wide range of diseases, including cancer, HIV/AIDS, and autoimmune disorders.
Biopharmaceuticals are typically more expensive to produce than traditional pharmaceuticals, but they offer a number of advantages, such as improved efficacy and fewer side effects. They are also more targeted, meaning they can be used to treat specific conditions more effectively.
Some of the major companies in the biopharmaceuticals market include Amgen, Biogen, Celgene, Gilead Sciences, and Novartis. These companies are involved in the development and production of a wide range of biopharmaceuticals, including monoclonal antibodies, vaccines, and gene therapies. Show Less Read more